• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Snehalatha Bhashyam 1 , P. Krishna Prasad 2 , B
Snehalatha Bhashyam 1 , P. Krishna Prasad 2 , B

... vomiting (PONV). Orally Disintegrating Film (ODF) formulations are novel and advanced oral drug delivery systems used in management of (PONV). We aimed to study the efficacy of ODF of Ondansetron in the prophylaxis of PONV and to compare it with intravenous Granisetron and placebo in patients underg ...
Fact Sheet: Quality of Life Outcomes in Prescription and Injection
Fact Sheet: Quality of Life Outcomes in Prescription and Injection

... 2. Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W et al. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015, 157:121-8. 3. Aden B, Dunning A, Nosyk B, Wittenberg E, Bray JW, Schackman BR. Imp ...


... is reported in the reference # 9, the percentageof side effect (SE) occurrence at the dosage of 1200mg/day is not negligible. The SE occurrence can be judged as dose dependent between 600mgIday and 1200mg/day,judging from the literature. At the generally prescribed dosageof 600mg/day, SE is thought ...
TGA to cancel ALL dextropropoxyphene products The TGA
TGA to cancel ALL dextropropoxyphene products The TGA

... Dextropropoxyphene Napsylate 100mg capsules, "Doloxene" The TGA, in considering all available evidence, concluded that the safety concerns with dextropropoxyphene outweighed the limited evidence of it's benefits over other avalable analgesics. The regulator cited recent evidence of cardiac toxicity, ...
Traditional and Herbal Medication Used in the Treatment of
Traditional and Herbal Medication Used in the Treatment of

... How does VNS work? • Exact anti-depressant mechanism unknown – Stimulation does affect blood flow in various regions of the brain – As a result, neurotransmitter activity increases, including 5-HT and NE which would have an anti-depressant affect • Side-effects: alteration of voice quality & loudne ...
Headache treatment:
Headache treatment:

... two or three times daily, with dose increases every four to five days based upon lithium levels; the typical maintenance dose is 900 to 1200 mg/day given in three to four divided doses of the regular formulation, or in two divided doses of the sustained release formulation. The lithium plasma level ...
Used Drugs to Treat Peptic Ulcer Disease
Used Drugs to Treat Peptic Ulcer Disease

... brain (chemoreceptor trigger zone). These drugs can be administered as a single dose prior to chemotherapy (IV or orally) and are efficacious against all grades of emetogenic therapy. These agents are extensively metabolized by the liver, Thus, doses of these agents should be adjusted in patients wi ...
Slide 1
Slide 1

... Topiramate is an oral, twice-daily, broad-spectrum AED indicated to treat: » Primary generalized tonic-clonic seizures20 » Partial-onset seizures21–23 » Seizures associated with LGS24,25 » Prophylaxis of migraine headaches26 ...
Management of Abstinence
Management of Abstinence

... • benzodiazepines • alpha-adrenergic agonist • anti-seizures • Propofol • barbiturates • neuroleptics • clomethiazole ...
Is  long-term  treatment  with  inhaled ... in  adults  hazardous? * J.
Is long-term treatment with inhaled ... in adults hazardous? * J.

... output. In the second study, Pouw et al. (23] showed that BDP administered for two weeks reduced the concentration of osteocalcin. Although these studies were not blind and the number of subjects studied was small, they indicate that inhaled steroids may interfere with bone metabolism. However, we d ...
Diagnosis and Treatment of Feline Asthma Including Use of Inhaled
Diagnosis and Treatment of Feline Asthma Including Use of Inhaled

... bronchitis and asthma. Chronic bronchitis is defined as an inflammatory disorder of the lower airways that causes a daily cough, for which other causes of cough (including heart failure, pneumonia, neoplasia etc) have been excluded. Asthma is more loosely defined as that disorder of the lower airway ...
The management of co-morbidities in patients with heart failure
The management of co-morbidities in patients with heart failure

... prospective observations showing in HF patients followed long term, higher baseline systolic, diastolic and pulse pressure levels were associated with higher rates of adverse events. [3] ...
Corticosteroids_November 2010 FINAL
Corticosteroids_November 2010 FINAL

... Note: wording for the PIL varies widely amongst products and the wording suggested below is largely based on patient-friendly wording taken from PILs which have undergone successful user-testing. Section 3 If you use more [product] than you should: It is important that you take your dose as stated o ...
Management of Gout - The British Society for Rheumatology
Management of Gout - The British Society for Rheumatology

... normal renal function or benzbromarone (50–200 mg/day) in patients with mild/moderate renal insufficiency (B). (7) Colchicine 0.5 mg bd should be co-prescribed following initiation of treatment with allopurinol or uricosuric drugs, and continued for up to 6 months (A). In patients who cannot tolerat ...
Muscle Relaxants
Muscle Relaxants

... - Respiratory: Ventilation; smokers have increased postop complications x6 - Decreased renal and hepatic function - Also: Weight, obesity, drug use, age (more risk with elderly) - These drugs have an affinity for nerve tissue. The overtin-Meyer theory states that the more lipid soluble a drug, the g ...
Managing Chemical & Radiological Exposure
Managing Chemical & Radiological Exposure

Prucalopride shared care guidelines
Prucalopride shared care guidelines

... Lubiprostone should not be used in patients with a known or suspected mechanical gastrointestinal obstruction. Contra-indicated in gastro-intestinal obstruction. May cause diarrhoea, avoid in patients who already have severe diarrhoea and instruct patients to report any signs of this. Dyspnoea or ch ...
Guidelines
Guidelines

... Additional requirements in US-FDA  In addition to a BE study under fasting conditions  BE study under fed conditions for all orally administered immediate-release drug products  Except: – When both test product and comparator are rapidly dissolving, have similar dissolution profiles, and contain ...
Reassessment of the dementia diagnosis of Alzheimer`s disease in
Reassessment of the dementia diagnosis of Alzheimer`s disease in

... dispensed by High Cost Drug stores (Exceptional Drugs Program). Methods: A prospective study to reassess the diagnosis of probable Alzheimer’s Disease was conducted (AD). The patients were submitted to the protocol of dementia investigation at the Neurogeriatric Outpatient Clinic of the Teaching Hos ...
Illegible Handwriting Illegible Handwriting Illegible Handwriting
Illegible Handwriting Illegible Handwriting Illegible Handwriting

Treatments Introduction to the Mechanism of Action of Different
Treatments Introduction to the Mechanism of Action of Different

... are largely inseparable. Biochemically, amphetamine releases catecholamines from their neuronal storage sites but does not greatly affect neuronal serotonin concentrations. The basic skeleton of amphetamine is one of a sympathomimetic amine. Axelrod showed that the reuptake block caused by amphetami ...
Antifungal Agents
Antifungal Agents

... and muscle pain, loss of weight, and fever - Anaphylactic shock - To reduce the toxicity of Amphotericin B, several new formulations have been developed in which amphotericin B is packaged in a lipid-associated delivery system (Liposomal preparations) ...
HYBANTHUS ENNEASPERMUS  Research Article
HYBANTHUS ENNEASPERMUS Research Article

Diuretics in Eng
Diuretics in Eng

... and t1/2 30–60 min. It acts on the ascending limb of Henley's loop by increasing urine excretion of Na+, Cl, Mg2+ and Ca2+. Its diuretic effect is achieved in 20–30 min after p.o. administration and lasts 4–6 h. Its effect after i.v. administration begins in 3–5 min and lasts 2 h. In low doses (5 to ...
jakavi - GuildLink
jakavi - GuildLink

... night sweats) anaemia (haemoglobin <100 g/L), leukocytosis (history of WBC >25 X 109/L) and circulating blasts ≥1%. The starting dose of Jakavi was based on platelet count. A baseline platelet count > 100 x 109/L was required for trial entry. Patients with a platelet count between 100 and 200X 109/ ...
< 1 ... 428 429 430 431 432 433 434 435 436 ... 684 >

Bilastine



Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report